AnaptysBio, Inc. Adds Dr. Jan de Vries, Dr. Nicholas Lydon and Dr. Phillip Patten to Advisory Boards
SAN DIEGO--(BUSINESS WIRE)--Three additional world-renowned scientists have been named to the scientific and therapeutic advisory boards of AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company: Jan de Vries, Ph.D., Nicholas B. Lydon, Ph.D. and Phillip A. Patten, Ph.D.